DNA

iMDx Reports Kidney Transplant Patient Achieved ‘Immune Reset’ with Novel Therapy and GraftAssure Monitoring

American Journal of Transplantation study positions GraftAssure as potentially essential in managing immunosuppression treatment in kidney transplant patients with certain...

AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform...

SafeTraces Selected as a Prime Performer for ARPA-H Building Resilient Environments for Air and Total Health (BREATHE) Program on Other Transaction Agreement up to $39 Million

Pioneering Dual-Use Technology Company Will Lead World-Class Team to Develop and Deploy Real-Time Biosensors, Risk Assessment Software, and Automated Building...

Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro – Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features

SOLNA, Sweden, Sept. 30, 2025 /PRNewswire/ -- Epigenica AB, the leader in epigenomic innovation, proudly announces the launch of the...

SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure

Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /...

SumHealth and Nucleus Genomics Partner to Bring Whole-Genome DNA Testing Into Healthcare Infrastructure

Partnership Makes Advanced, Clinical-Grade Genetic Insights Affordable and Accessible Through Hospitals, Pharmacies and Healthcare Systems Nationwide CHARLOTTE, NORTH CAROLINA /...

Embleema Awarded $5M Department of Defense Contract. Partners With GRAVL and Aria Diagnostics to Create Global Pathogen Bio Surveillance Infrastructure

BOSTON, Sept. 29, 2025 /PRNewswire/ -- Embleema, in partnership with GRAVL and Aria Diagnostics (ARIA), has secured a $5 million...

Onco-Innovations Advances Preclinical Program as Nucro-Technics Begins Analytical Development for PNKP Technology

VANCOUVER, BC / ACCESS Newswire / September 29, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN:A3EKSZ) ("Onco" or the "Company") is pleased...

error: Content is protected !!